Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-04-13

FDA Approved: NORTRIPTYLINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

The FDA approved Teva's supplemental application for Nortriptyline hydrochloride (generic) under anANDA, updating the approval of this product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nortriptyline Hydrochloride (Nortriptyline hydrochloride)

Snippet

SUPPL AP for NORTRIPTYLINE HYDROCHLORIDE (NORTRIPTYLINE HYDROCHLORIDE)